Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Abroad (travel likely)Recruiting
Conditions
Recurrent CNS Tumors · Brain Cancer · Gliomas · IDH-wildtype Gliomas · IDH-mutant Gliomas · Rare CNS Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · ncimo_referrals@mail.nih.gov · 888-624-1937
Study leads
Jing Wu, M.D.
Principal Investigator
National Cancer Institute (NCI)